Jones Ventures INTL Acquisition1 Corp

For investors tracking redemption deadlines, trust value, extensions, deal progress, and sponsor conduct: (1) Trust value is $203,955,000, or $10.00 per public share, as of July 31, 2026. (2) The 21-month deadline from the July 15, 2026 IPO closing gives an initial deadline of April 14, 2028. (3) No deal progress – the company confirms it has not selected any target and has not initiated any discussions. (4) Sponsor conduct includes: the lead underwriter is an affiliate of the sponsor; the sponsor transferred 460,000 founder shares to independent directors; the sponsor is entitled to a $20,000/month administrative fee; working capital loans of up to $1.5 million may be converted into units at $10.00 per unit; and the company will pay the sponsor-affiliated underwriter a 4.0% fee on the IPO gross proceeds ($8,000,000) upon consummation of a business combination. (5) No extension mechanism is described beyond the standard 21-month period.

For investors monitoring trust mechanics and sponsor conduct, the filing quantifies the exact capital structure and expense profile prior to target selection. The Company discloses $4,960,192 in total transaction costs, broken down as $4,000,000 in cash underwriting fees and $960,192 in other offering costs. Management attributes a 15% maximum redemption limit per public shareholder to the Amended and Restated Memorandum and Articles, absent prior consent, and establishes an 80% of trust assets fair market value threshold for any targeted acquisition. The Sponsor's compensation exposure is detailed: JonesTrading Institutional Services LLC receives $8,000,000 (4.0% of IPO gross proceeds) plus up to $9,800,000 (6.0% of overallotment) exclusively upon business combination consummation, while Odeon Capital Group LLC received a fixed $100,000 fee. Auditing firm CBIZ CPAs P.C. certifies the July 15, 2026 balance sheet showing $1,614,681 in operating cash, $22,063 in prepaid expenses, $200,000,000 in the Trust Account, $451,651 in total liabilities, and $1,185,093 in shareholders' equity. The filing further notes that management applied a third-party Monte Carlo Simulation Model to value 460,000 transferred founder shares at an aggregate fair value of $448,500 ($0.98 per share), utilizing assumed inputs of a $9.88 stock price, 3.66% risk-free rate, and 9.90% market adjustment, with recognition deferred until a business combination becomes probable. No operating revenues or target negotiations have been initiated as of the balance sheet date, and management cites geopolitical volatility from conflicts in Ukraine and the Middle East as a potential disruption factor for capital markets and target searches.

This filing establishes the SPAC's baseline trust value ($10.00 per share), the 21-month deadline (April 2028), the lock-up periods for founder shares (one year after business combination, or earlier if price condition met) and private placement units (30 days after business combination), the sponsor's voting and non-redemption commitments, and the terms of the business combination marketing fee (4% of gross proceeds, $8 million, payable at closing). It also confirms the trust structure and allowable uses of interest (taxes and up to $100,000 dissolution expenses). All of these are critical for investors tracking redemption deadlines, trust value, and sponsor conduct.

Jones Ventures is a rights-only vehicle, so there is no warrant strike, expiry or warrant redemption trigger to record; a null in those fields is the filed answer rather than a coverage gap. The 21-month deadline runs from closing and is extended only by shareholder approval of an amendment to the memorandum and articles of association. Working capital loans may convert into units of the post-combination entity at $10.00 per unit, which the prospectus identifies as a source of material dilution to public shareholders.

This is a standard SPAC IPO. It establishes the timeline (21 months), trust value ($10.00/share), and conflicts of interest (sponsor/underwriter are affiliates; $8M marketing fee is contingent on completion; founder shares purchased at a nominal price create substantial dilution and incentive to close any deal). No target has been selected. The nominal price of founder shares ($0.003) vs. public offering price ($10.00) means holders could make a substantial profit even if the post-business combination stock price declines materially.

For investors tracking redemption mechanics, the trust value remains $10.00 per public share with a 21-month deadline from the offering closing (potential extensions up to 36 months with shareholder vote). The filing confirms no substantive deal discussions have occurred. Sponsor conduct details include a nominal $0.003 per founder share cost, a $8.0 million business combination marketing fee to the underwriter (JonesTrading), and significant potential dilution for public shareholders. The updated financials show a working capital deficit and going-concern uncertainty, underscoring the need for the IPO proceeds.

What changed: Jones Ventures INTL Acquisition1 Corp announced that commencing September 3, 2026, holders of its initial public offering units may elect to separately trade Class A Ordinary Shares (symbol JONE) and Share Rights (symbol JONER), while separated units continue trading as JONEU. Why it matters: This filing confirms the mechanical separation of securities for a SPAC in the SEARCHING status, allowing investors to trade the underlying equity and rights independently ahead of the April 14, 2028 redemption deadline.

What changed: 10-Q quarterly report for the period ended June 30, 2026, filed by Jones Ventures INTL Acquisition1 Corp, a blank-check company still searching for a target. The 10-Q covers the pre-IPO period (ended June 30, 2026). The IPO was completed after quarter end on July 15, 2026, raising $200,000,000 from 20,000,000 units at $10.00 per unit, plus $3,955,000 from partial over-allotment exercise on July 31, 2026. The trust account now holds $203,955,000 ($10.00 per public share). The sponsor’s $300,000 promissory note and $70,657 in related-party advances were repaid after quarter end. Founder shares were transferred to independent directors at $0.003 per share, with $448,500 in share-based compensation to be recognized upon a business combination. The company has 21 months from the IPO closing (until April 14, 2028) to complete a business combination. No target has been identified or discussions initiated. Why it matters: For investors tracking redemption deadlines, trust value, extensions, deal progress, and sponsor conduct: (1) Trust value is $203,955,000, or $10.00 per public share, as of July 31, 2026. (2) The 21-month deadline from the July 15, 2026 IPO closing gives an initial deadline of April 14, 2028. (3) No deal progress – the company confirms it has not selected any target and has not initiated any discussions. (4) Sponsor conduct includes: the lead underwriter is an affiliate of the sponsor; the sponsor transferred 460,000 founder shares to independent directors; the sponsor is entitled to a $20,000/month administrative fee; working capital loans of up to $1.5 million may be converted into units at $10.00 per unit; and the company will pay the sponsor-affiliated underwriter a 4.0% fee on the IPO gross proceeds ($8,000,000) upon consummation of a business combination. (5) No extension mechanism is described beyond the standard 21-month period.

What changed: SEC Form 8-K Current Report detailing the July 15, 2026 consummation of the initial public offering, the simultaneous private placement, the audited balance sheet, and the execution of founding, underwriting, administrative, and business combination marketing agreements. According to the Company's filing, the IPO of 20,000,000 units closed on July 15, 2026, with each unit priced at $10.00, generating $200,000,000 in gross proceeds. The Company states that $200,000,000 was placed into a U.S.-based trust account at Citibank Bank, N.A., with Equiniti Trust Company, LLC acting as trustee. Simultaneously, the Company reports the private sale of 645,000 units to the Sponsor and underwriters at $10.00 per unit, yielding $6,450,000. The filing notes a 21-month combination period commencing on the IPO closing date, an unexercised 45-day over-allotment option for 3,000,000 additional units, and the commencement of a $20,000 per month administrative support agreement with the Sponsor on July 13, 2026. The Sponsor and initial shareholders agreed to waive redemption and liquidation rights regarding founder and private placement shares, while retaining the right to vote in favor of a business combination and to convert up to $1,500,000 of working capital loans into Class A ordinary shares at $10.00 per unit beginning 60 days after the IPO. Why it matters: For investors monitoring trust mechanics and sponsor conduct, the filing quantifies the exact capital structure and expense profile prior to target selection. The Company discloses $4,960,192 in total transaction costs, broken down as $4,000,000 in cash underwriting fees and $960,192 in other offering costs. Management attributes a 15% maximum redemption limit per public shareholder to the Amended and Restated Memorandum and Articles, absent prior consent, and establishes an 80% of trust assets fair market value threshold for any targeted acquisition. The Sponsor's compensation exposure is detailed: JonesTrading Institutional Services LLC receives $8,000,000 (4.0% of IPO gross proceeds) plus up to $9,800,000 (6.0% of overallotment) exclusively upon business combination consummation, while Odeon Capital Group LLC received a fixed $100,000 fee. Auditing firm CBIZ CPAs P.C. certifies the July 15, 2026 balance sheet showing $1,614,681 in operating cash, $22,063 in prepaid expenses, $200,000,000 in the Trust Account, $451,651 in total liabilities, and $1,185,093 in shareholders' equity. The filing further notes that management applied a third-party Monte Carlo Simulation Model to value 460,000 transferred founder shares at an aggregate fair value of $448,500 ($0.98 per share), utilizing assumed inputs of a $9.88 stock price, 3.66% risk-free rate, and 9.90% market adjustment, with recognition deferred until a business combination becomes probable. No operating revenues or target negotiations have been initiated as of the balance sheet date, and management cites geopolitical volatility from conflicts in Ukraine and the Middle East as a potential disruption factor for capital markets and target searches.

What changed: Form 8-K reporting the consummation of the SPAC's initial public offering and the entry into related agreements, including the underwriting agreement, trust agreement, charter amendments, and private placement. The SPAC completed its IPO of 20,000,000 units at $10.00 per unit for gross proceeds of $200 million, and a concurrent private placement of 645,000 units to sponsor and underwriter for $6.45 million. The funds were deposited into a trust account at Citibank with Equiniti as trustee. The trust holds $200 million (plus a portion of private placement proceeds) and the deadline to complete a business combination is 21 months from the closing date (July 15, 2026), i.e., April 14, 2028. The amended charter and all standard IPO agreements were adopted. Why it matters: This filing establishes the SPAC's baseline trust value ($10.00 per share), the 21-month deadline (April 2028), the lock-up periods for founder shares (one year after business combination, or earlier if price condition met) and private placement units (30 days after business combination), the sponsor's voting and non-redemption commitments, and the terms of the business combination marketing fee (4% of gross proceeds, $8 million, payable at closing). It also confirms the trust structure and allowable uses of interest (taxes and up to $100,000 dissolution expenses). All of these are critical for investors tracking redemption deadlines, trust value, and sponsor conduct.

What changed: A Form 4 insider ownership report. The filing states that Hill Alan Finbar, identified as director and Chief Executive Officer, recorded zero non-derivative transactions or holdings changes. Regarding your tracked mechanics, this submission provides no updates to redemption calendars, trust account maintenance, extension voting procedures, merger negotiation status, or sponsor conduct. Why it matters: According to the report, the absence of disclosed trades offers no data point regarding management conviction, personal liquidity pressure, or strategic share accumulation ahead of target identification. Because the Form 4 contains no activity, it does not shift funding requirements, alter shareholder rights, or introduce any developments concerning customer pipelines, revenue generation, market sizing, corporate strategy, technology deployment, partnership formations, litigation exposure, or executive personnel changes.